Holdings A/S Novo, a major owner of Corvus Pharmaceuticals, Inc., has just filed an initial statement of beneficial ownership where 2,927,560 shares of Corvus Pharmaceuticals, Inc. were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Novo. Novo operates out of Hellerup, G7. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020